Published in Am J Med on August 01, 2003
Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology (2012) 7.15
Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med (2008) 6.99
Overuse of screening colonoscopy in the Medicare population. Arch Intern Med (2011) 3.08
Improving colorectal cancer screening in primary care practice: innovative strategies and future directions. J Gen Intern Med (2007) 2.26
Screening colonoscopies by primary care physicians: a meta-analysis. Ann Fam Med (2009) 1.78
Assessment of the quality of colonoscopy reports: results from a multicenter consortium. Gastrointest Endosc (2009) 1.64
The Your Disease Risk Index for colorectal cancer is an inaccurate risk stratification tool for advanced colorectal neoplasia at screening colonoscopy. Cancer Prev Res (Phila) (2012) 1.48
The cost-effectiveness of CT colonography in screening for colorectal neoplasia. Am J Gastroenterol (2006) 1.23
Potentially inappropriate screening colonoscopy in Medicare patients: variation by physician and geographic region. JAMA Intern Med (2013) 1.22
Many patients who undergo surgery for colorectal cancer receive surveillance colonoscopies earlier than recommended by guidelines. Clin Gastroenterol Hepatol (2012) 1.22
Colonoscopy and flexible sigmoidoscopy practice patterns in Ontario: a population-based study. Can J Gastroenterol (2007) 1.19
Improving the quality of colorectal cancer screening: assessment of familial risk. Dig Dis Sci (2010) 1.00
Physician reminders to promote surveillance colonoscopy for colorectal adenomas: a randomized controlled trial. J Gen Intern Med (2008) 0.99
Socioeconomic and physician supply determinants of racial disparities in colorectal cancer screening. J Oncol Pract (2012) 0.98
Colonoscopist and primary care physician supply and disparities in colorectal cancer screening. Health Serv Res (2011) 0.96
New Mexico's capacity for increasing the prevalence of colorectal cancer screening with screening colonoscopies. Prev Chronic Dis (2004) 0.91
Intraurban influences on physician colorectal cancer screening practices. J Natl Med Assoc (2007) 0.89
Quality and safety of screening colonoscopies performed by primary care physicians with standby specialist support. Med Care (2010) 0.89
Non-English speakers attend gastroenterology clinic appointments at higher rates than English speakers in a vulnerable patient population. J Clin Gastroenterol (2009) 0.83
Prevention, screening and treatment of colorectal cancer: a global and regional generalized cost effectiveness analysis. Cost Eff Resour Alloc (2010) 0.80
Predicting the risk of recurrent adenoma and incident colorectal cancer based on findings of the baseline colonoscopy. Clin Transl Gastroenterol (2014) 0.78
Should prior FIT results be incorporated as an additional variable to estimate risk of colorectal neoplasia? A prospective study of 5,813 screening colonoscopies. PLoS One (2014) 0.75
The discriminatory capability of existing scores to predict advanced colorectal neoplasia: a prospective colonoscopy study of 5,899 screening participants. Sci Rep (2016) 0.75
Validity of APCS score as a risk prediction score for advanced colorectal neoplasia in Chinese asymptomatic subjects: A prospective colonoscopy study. Medicine (Baltimore) (2016) 0.75
Potential capacity of endoscopic screening for gastric cancer in Japan. Cancer Sci (2016) 0.75
Concerns and challenges in flexible sigmoidoscopy screening. Colorectal Cancer (2012) 0.75
Endoscopic colorectal cancer screening--can supply meet demand? Gastroenterology (2004) 0.75
Test-positive rate at CT colonography is increased by rectal bleeding and/or unexplained weight loss, unlike other common gastrointestinal symptoms. Eur J Radiol Open (2015) 0.75
Prevalence and predictors of patient no-shows to outpatient endoscopic procedures scheduled with anesthesia. BMC Gastroenterol (2015) 0.75
Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care (2002) 21.63
Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev (2006) 6.67
Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer (2004) 6.41
Utility of the SEER-Medicare data to identify chemotherapy use. Med Care (2002) 5.07
Are physicians doing too much colonoscopy? A national survey of colorectal surveillance after polypectomy. Ann Intern Med (2004) 4.49
Use of SEER-Medicare data for measuring cancer surgery. Med Care (2002) 4.27
Studying radiation therapy using SEER-Medicare-linked data. Med Care (2002) 4.13
Colorectal cancer test use from the 2005 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev (2008) 3.64
Linking physician characteristics and medicare claims data: issues in data availability, quality, and measurement. Med Care (2002) 3.36
Adverse events after outpatient colonoscopy in the Medicare population. Ann Intern Med (2009) 3.34
Differences between primary care physicians' and oncologists' knowledge, attitudes and practices regarding the care of cancer survivors. J Gen Intern Med (2011) 3.11
A national survey of primary care physicians' methods for screening for fecal occult blood. Ann Intern Med (2005) 3.01
Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity? J Clin Oncol (2008) 2.62
In search of the perfect comorbidity measure for use with administrative claims data: does it exist? Med Care (2006) 2.53
Barriers to breast and colorectal cancer survivorship care: perceptions of primary care physicians and medical oncologists in the United States. J Clin Oncol (2013) 2.32
Patterns of colorectal cancer test use, including CT colonography, in the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev (2012) 2.31
Cancer, comorbidities, and health-related quality of life of older adults. Health Care Financ Rev (2008) 2.20
Measuring complications of cancer treatment using the SEER-Medicare data. Med Care (2002) 2.05
Data sources for measuring colorectal endoscopy use among Medicare enrollees. Cancer Epidemiol Biomarkers Prev (2007) 2.02
Health care provider surveys in the United States, 2000-2010: a review. Eval Health Prof (2013) 2.02
Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer. J Gen Intern Med (2004) 1.97
Physician use of genetic testing for cancer susceptibility: results of a national survey. Cancer Epidemiol Biomarkers Prev (2003) 1.83
Colorectal cancer screening barriers and facilitators in older persons. Prev Med (2009) 1.73
Cancer screening test use - United States, 2013. MMWR Morb Mortal Wkly Rep (2015) 1.72
Trends in colorectal cancer test use in the medicare population, 1998-2005. Am J Prev Med (2009) 1.68
Comorbidity-adjusted life expectancy: a new tool to inform recommendations for optimal screening strategies. Ann Intern Med (2013) 1.62
Population-based survivorship research using cancer registries: a study of non-Hodgkin's lymphoma survivors. J Cancer Surviv (2007) 1.56
Primary care, economic barriers to health care, and use of colorectal cancer screening tests among Medicare enrollees over time. Ann Fam Med (2010) 1.47
A population-based study of colorectal cancer test use: results from the 2001 California Health Interview Survey. Cancer (2004) 1.45
Are physicians' recommendations for colorectal cancer screening guideline-consistent? J Gen Intern Med (2010) 1.44
Racial and ethnic trends of colorectal cancer screening among Medicare enrollees. Am J Prev Med (2010) 1.42
Measuring breast, colorectal, and prostate cancer screening with medicare claims data. Med Care (2002) 1.37
Physicians' colorectal cancer screening discussion and recommendation patterns. Cancer Epidemiol Biomarkers Prev (2011) 1.35
Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer. Med Care (2004) 1.31
Screening colonoscopy in the US: attitudes and practices of primary care physicians. J Gen Intern Med (2012) 1.30
Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes study. J Gen Intern Med (2003) 1.30
Assessing non-cancer-related health status of US cancer patients: other-cause survival and comorbidity prevalence. Am J Epidemiol (2013) 1.29
Systems strategies to support cancer screening in U.S. primary care practice. Cancer Epidemiol Biomarkers Prev (2011) 1.28
Evaluation of claims, medical records, and self-report for measuring fecal occult blood testing among medicare enrollees in fee for service. Cancer Epidemiol Biomarkers Prev (2008) 1.24
Are there gender differences in colorectal cancer test use prevalence and correlates? Cancer Epidemiol Biomarkers Prev (2006) 1.22
Use of lung cancer screening tests in the United States: results from the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev (2012) 1.22
Racial differences in colorectal cancer test use by Medicare consumers. Am J Prev Med (2006) 1.16
Fecal occult blood testing beliefs and practices of U.S. primary care physicians: serious deviations from evidence-based recommendations. J Gen Intern Med (2010) 1.16
Breast cancer screening beliefs, recommendations and practices: primary care physicians in the United States. Cancer (2011) 1.12
National evidence on the use of shared decision making in prostate-specific antigen screening. Ann Fam Med (2013) 1.11
Multiple clinical practice guidelines for breast and cervical cancer screening: perceptions of US primary care physicians. Med Care (2011) 1.10
Life tables adjusted for comorbidity more accurately estimate noncancer survival for recently diagnosed cancer patients. J Clin Epidemiol (2013) 1.10
Breast and colorectal cancer screening: U.S. primary care physicians' reports of barriers. Am J Prev Med (2012) 1.10
Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening: A Retrospective Cohort Study. Ann Intern Med (2016) 1.10
Association of polypectomy techniques, endoscopist volume, and facility type with colonoscopy complications. Gastrointest Endosc (2013) 1.07
Comparison of cancer diagnosis and treatment in Medicare fee-for-service and managed care plans. Med Care (2008) 1.07
Enrollment of patients with lung and colorectal cancers onto clinical trials. J Oncol Pract (2013) 1.05
Physician recommendations for follow-up of positive fecal occult blood tests. Med Care Res Rev (2005) 0.97
Physician over-recommendation of mammography for terminally ill women. Cancer (2011) 0.97
The contribution of longitudinal comorbidity measurements to survival analysis. Med Care (2009) 0.96
Multilevel predictors of colorectal cancer screening use in California. Am J Manag Care (2013) 0.95
Comorbidities, therapy, and newly diagnosed conditions for women with early stage breast cancer. J Cancer Surviv (2009) 0.94
Comparing interval breast cancer rates in Norway and North Carolina: results and challenges. J Med Screen (2009) 0.94
Variations in surgeon treatment recommendations for lobectomy in early-stage non-small-cell lung cancer by patient age and comorbidity. Ann Surg Oncol (2010) 0.93
Association of regional variation in primary care physicians' colorectal cancer screening recommendations with individual use of colorectal cancer screening. Prev Chronic Dis (2007) 0.92
Adoption of CT colonography by US hospitals. J Am Coll Radiol (2011) 0.91
Communicating breast cancer risk: patient perceptions of provider discussions. Medscape Womens Health (2002) 0.91
Variation in primary care physicians' colorectal cancer screening recommendations by patient age and comorbidity. J Gen Intern Med (2012) 0.90
Physicians' beliefs about breast cancer surveillance testing are consistent with test overuse. Med Care (2013) 0.86
Physicians' use of nonphysician healthcare providers for colorectal cancer screening. Am J Prev Med (2003) 0.84
Data systems to evaluate colorectal cancer screening practices and outcomes at the population level. Med Care (2008) 0.80
Colorectal cancer screening perceptions and practices: results from a national survey of gastroenterology, surgery and radiology trainees. J Cancer Educ (2007) 0.79
Physician visits and colorectal cancer testing among Medicare enrollees in North Carolina and South Carolina, 2005. Prev Chronic Dis (2011) 0.78
Organization of primary care practice for providing energy balance care. Am J Health Promot (2013) 0.77
Increasing colorectal cancer testing: translating physician interventions into population-based practice. Health Care Financ Rev (2006) 0.76
Physician-reported barriers to referring cancer patients to specialists: prevalence, factors, and association with career satisfaction. Cancer (2014) 0.75
Reply to U. Tirelli et al. J Clin Oncol (2013) 0.75